Narula Sanjeev

Phathom Pharmaceuticals, Inc. · Chief Financial & Bus. Officer

Narula Sanjeev is listed in filings as Chief Financial & Bus. Officer at Phathom Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 2, 2026, including 9 public disclosures. Recent filings connect the profile to Phathom Pharmaceuticals, Inc. (PHAT) and Intra-Cellular Therapies Inc. (ITCI) (ITCI). The current snapshot covers public activity from Aug 14, 2024 to Jan 2, 2026. Reported amounts are shown as $673.1K to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.
Narula Sanjeev History Trades | TradingNote